| Identification | Back Directory | [Name]
Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)- , (1alpha,6alpha,14alpha,15alpha,16beta)- | [CAS]
80665-72-1 | [Synonyms]
Senbusine C
15-Epinagarine
15-Hydroxyneoline
15-α-hydroxyneoline
Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)- ,
Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)-, (1α,6α,14α,15α,16β)-
Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)- , (1alpha,6alpha,14alpha,15alpha,16beta)- | [Molecular Formula]
C24H39NO7 | [MDL Number]
MFCD22124992 | [MOL File]
80665-72-1.mol | [Molecular Weight]
453.58 |
| Chemical Properties | Back Directory | [Melting point ]
206-207℃ | [Boiling point ]
596.9±50.0 °C(Predicted) | [density ]
1.36±0.1 g/cm3 (20 ºC 760 Torr) | [solubility ]
Chloroform: soluble; DMSO: soluble | [form ]
A crystalline solid | [pka]
12.78±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Fuziline is a drug used as an analyte or reagent for research on the cardiovascular system and therapeutic use. | [Definition]
ChEBI: Fuziline is a diterpene alkaloid. It is functionally related to an aconitane. |
|
|